Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Perspective Therapeutics (CATX) Tax Provisions (2023)

Perspective Therapeutics' Tax Provisions history spans 1 years, with the latest figure at $7.8 million for Q4 2023.

  • For Q4 2023, Tax Provisions changed N/A year-over-year to $7.8 million; the TTM value through Dec 2023 reached -$2.7 million, changed N/A, while the annual FY2023 figure was -$2.7 million, N/A changed from the prior year.
  • Tax Provisions for Q4 2023 was $7.8 million at Perspective Therapeutics, up from -$10.5 million in the prior quarter.
  • Across five years, Tax Provisions topped out at $7.8 million in Q4 2023 and bottomed at -$10.5 million in Q1 2023.